Ernest Beutler, 80, Dies; Studied Blood Diseases Oct 10, 2008
In the 1980s, Dr. Beutler and his colleagues at Scripps developed and tested a new drug, 2-CdA, which was found to be highly effective in treating hairy cell leukemia, a rare but potentially fatal disease of the blood and bone marrow. With Dr. Dennis A. Carson, Dr. Lawrence D. Piro and others, Dr. Beutler attacked abnormal white blood cells in leukemia patients using a single infusion of the new drug, which was modeled in part on an enzyme that breaks down a toxic byproduct of normal cellular... (Atlanta Journal-Constitution -- Health)
More than 1,000 people show up for Livingston Co. Relay for Life Aug 9, 2008
One survivor, Val Boucher of Roanoke, who fought hairy cell leukemia several years ago, challenged those in attendance to fight back through treatment, fundraising and support. It is time for you yourselves to take action and make a difference, he said. (The Pantagraph newspaper)
Canada should follow the U.S. example on 'orphan' diseases Jul 18, 2008
While there are scores of drugs for those with cardiovascular ailments, a bevy of antidepressants and antibiotics, and more anti-impotence treatments than the world will ever need, there is a paucity of medications for pulmonary hypertension (the rare disorder that claimed the life of Mr. Bell's grandson), cervical dystonia, hairy cell leukemia and so on. There is little incentive for drug companies to do research on possible treatments for conditions that affect dozens or hundreds of people. (Globe and Mail)
Hodgkin Lymphoma Risk: Why Disease Affects Some, And Not Others; New Hypothesis From Twins Study Apr 6, 2008
4, 2008) A long-term study of twins has led University of Southern California (USC) researchers to find potential links between Hodgkin lymphoma and levels of an immune response protein (interleukin-12). "We found that lower levels of the protein interleukin-12, involved in fighting intracellular infections, increases susceptibility to young adult Hodgkin lymphoma," says Wendy Cozen, D.O., M.P.H, associate professor of preventive medicine at the Keck School of Medicine of USC. " Cozen is lead... (Science Daily)
PLACES OF WORSHIP: Redeemer Lutheran Church Feb 9, 2008
Eisberg has had to deal with hairy cell leukemia, which has been eradicated, and prostate cancer, which doctors continue to monitor with regular checkups. The basicsLocation: 1084 W. Bullard Ave.Contacts: (559) 439-8500; online, redeemerfresno. (Fresno Bee -- Lifestyle)
Bedford Laboratories(TM) to Begin Shipping Pentostatin for Injection Aug 14, 2007
This product is AP rated and is equivalent to Nipent(R) by Hospira Inc. Pentostatin is indicated for the treatment of hairy cell leukemia. (Logo: ) "In our continuing effort to offer the most comprehensive and cost effective line of oncology and oncology adjunct products in the multisource industry, Bedford Laboratories is once again very pleased to offer this very important product," said David Gaugh, Vice President of Bedford Laboratories. (PR Newswire)
Hit with chemo full force Jul 19, 2007
Vonnie was diagnosed with Hairy Cell Leukemia and in Relay for Life terminology is now characterized as a three year survivor. Thinking back to the day when she received her diagnosis, Vonnie recalls telling her husband, Norman, while sitting in the clinic waiting room, I dont know why were here. (Mt. Lake Observer/Advocate, MN)
Study Analyzes Heart Attack Mortality Risk Associated With Hodgkin Disease Treatments Feb 9, 2007
(February 8, 2007) -- Survivors of a rare cancer called hairy cell leukemia are at an increased risk of Hodgkin lymphoma, non-Hodgkin lymphoma, and thyroid cancer, and at an increased risk of death from leukemia and. . (Science Daily)
Study Examines Second Cancer Risk Among Hairy Cell Leukemia Survivors Feb 9, 2007
Survivors of a rare cancer called hairy cell leukemia are at an increased risk of Hodgkin lymphoma, non-Hodgkin lymphoma, and thyroid cancer, and at an increased risk of death from leukemia and lymphoma, according to a new study ... Hairy cell leukemia is a malignancy of a type of white blood cell called B lymphocytes ... D., and colleagues at the National Cancer Institute examined the records for 3,104 patients with hairy cell leukemia who survived for at least two months after diagnosis. (Science Daily)
